Anil Kapur

Anil Kapur

Director/Board Member at VERASTEM, INC.

Net worth: 228 044 $ as of 31/05/2026

56 year
Health Technology
Consumer Services

Profile

Anil Kapur is currently an Independent Director at Verastem, Inc. since 2022, an independent Director at Nurix Therapeutics, Inc. since 2024, and Head-Legal at Sagar Ratna Restaurants Pvt Ltd. Former positions include Chief Commercial Officer & EVP-Corporate Strategy at Geron Corp.
from 2019 to 2024, Chief Commercial Officer at Actinium Pharmaceuticals, Inc. from 2018 to 2019, Vice President, Head-Early Assets & Biomarkers at Bristol Myers Squibb Co. from 2016 to 2018, VP, Global Head-Commercial & Portfolio Strategy at Baxalta, Inc. from 2015 to 2016, VP & Commercial Leader-Hematology Franchise at Johnson & Johnson from 2013 to 2015, and Legal Advisor at Paras Group.
Education includes undergraduate studies at Birla Institute of Technology & Science and Kurukshetra University, graduate studies at Louisiana Tech University and Kurukshetra University, and an MBA from The Fuqua School of Business.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
21/05/2026 52,666 ( 0.09% ) 228 044 $ 31/05/2026
15/05/2026 0 ( -.--% ) - $ 31/05/2026

Anil Kapur active positions

CompaniesPositionStart
VERASTEM, INC. Director/Board Member 20/10/2022
NURIX THERAPEUTICS, INC. Director/Board Member 15/10/2024
General Counsel -

Former positions of Anil Kapur

CompaniesPositionEnd
GERON CORPORATION Corporate Officer/Principal 31/08/2024
ACTINIUM PHARMACEUTICALS, INC. Corporate Officer/Principal 29/11/2019
BRISTOL-MYERS SQUIBB COMPANY Corporate Officer/Principal 01/02/2018
BAXALTA INC Corporate Officer/Principal 01/07/2016
JOHNSON & JOHNSON Corporate Officer/Principal 01/11/2015
See the detail of Anil Kapur's experience

Training of Anil Kapur

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

78

1st degree connections

13

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies13

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Consumer Services

Health Technology

Consumer Services

Health Technology

Consumer Services

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!